Augmenta Bioworks is Drug Discovery in United States that focus on throughput DNA sequencing business. Founded in 2016. They cover business area such as developer, novel therapeutic, infectious disease, unmet need, automation, microfluidic, high throughput dna sequencing, computational analysis, immune receptor, their antigen specificity, antibody, patient, global immunity.
2016
( 8 years old in 2024 )
Throughput DNA Sequencing
-
3475 Edison Way
Unit K
Menlo Park, CA 94025
United States
Private
developernovel therapeuticinfectious diseaseunmet needautomationmicrofluidichigh throughput dna sequencingcomputational analysisimmune receptortheir antigen specificityantibodypatientglobal immunity
* We use standard office opening hours in near Augmenta Bioworks's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Augmenta Bioworks is Drug Discovery business from United States that founded in 2016 (8 years old in 2024), Augmenta Bioworks business is focusing on Throughput DNA Sequencing.
Augmenta Bioworks headquarter office and corporate office address is located in 3475 Edison Way Unit K Menlo Park, CA 94025 United States.
Augmenta Bioworks was founded in United States.
In 2024, Augmenta Bioworks is currently focus on throughput DNA sequencing sector.
Above is snippet of Google Trends for "throughput DNA sequencing" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Augmenta Bioworks, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
